HomeTrading IdeasUS Dollar Gains as...

US Dollar Gains as Tariff Letters Erode Risk Appetite

  • Trump letters and August 1 deadline in focus
  • Dollar strengthens as both China and the EU avoid tariff letters
  • Equities are wobbly, while gold confirms lingering demand
  • Aussie gains as RBA surprises by keeping rates unchanged

Liberation Date: Version 2

The approval of the US Budget Bill has allowed US President Trump to shift his focus to his second most favorite subject: tariffs. Three months after the April 2 Liberation Day and the show in the Rose Garden, Trump kicked the can down the road by extending the 90-day pause on reciprocal tariffs to August 1.

In the meantime, 14 countries – including Japan and South Korea – received a letter detailing the potential imposition of harsh tariffs, ranging from 24% to 48%, if these nations do not accept Trump’s demands by August 1. Interestingly, the EU and India did not receive a ‘Trump tariff letter’, suggesting that negotiations are underway and the US President is satisfied with the progress made so far.

Market Switched To Risk-Off Mode

Upon news that both Japan and South Korea received the Trump letter, the market reacted in a risk-off fashion, with the receiving a boost and rallying against both the and . Notably, this reaction differs from the market moves following the April 2 reciprocal announcements. That date marked the start of the dollar’s underperformance, which has led to hovering north of 1.17.

The appears to be in trouble, as Japanese PM Ishiba’s determination to protect Japan’s critical sectors is drawing Trump’s ire. Interestingly, Upper House elections will be held on July 20 in Japan. The latest developments could either boost Ishiba’s chances of maintaining the simple majority his party currently holds in the Upper House, or confirm the current low approval ratings, potentially causing Ishiba to lose support and even triggering the collapse of his minority government. Dollar/yen is currently climbing towards the 146.20 area, though a decisive move above 148 is needed to support a bullish breakout.

Meanwhile, equities are slightly on the back foot, although the reaction has been muted, potentially due to the fact that both China and the EU are currently not being targeted by Trump. , though, got a quick boost, rising almost $40 from the $3,300 level, despite the dollar performing relatively well yesterday. Although the precious metal has not been making headlines lately, it remains supported by lingering demand, particularly when it tests the $3,260 area.

Focus on Additional Letters and Headlines About the US-EU Progress

Investors will probably remain glued to their screens, looking for any additional countries that might receive Trump’s letter, and information on the US-EU trade negotiations progress. Considering Trump’s style, we cannot rule out the possibility of a brief deterioration in the US-EU relations, engineered by the US President to achieve his objectives.

In the meantime, it won’t be long before Trump shifts his focus to the . One of the rumoured candidates for the Fed Chair position, former Fed Reserve Governor Warsh, is hitting all the right notes. At his latest appearance, he downplayed inflation risks due to tariffs and detailed his vision for a ‘new’ Fed, brought into the 21st century. The credibility of the Fed as an institution is at risk if this process becomes a beauty pageant.

RBA Stands Pat, Maintains Dovish Stance

Despite potent market expectations, the RBA chose to stand pat, keeping its rates unchanged and essentially opting to wait for more information. Considering the latest developments on the tariff front – with Australia not getting a letter but not completely out of the woods yet – and the much-expected release of the report for the second quarter of 2025 in late-July, today’s decision makes sense.

Notably, the got an unexpected boost, reacting to Monday’s sizeable dollar rally and testing the 0.6548 level again.

However, the move is gradually fading, as the RBA remains on an easing path and, if conditions demand it, a stronger could be delivered on August 12.Economic Calendar

Most Popular

More from Author

Read Now

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a tipping point, the herd realizes the tide has reversed and it’s time to sell--but alas, it’s too late. Illiquid, Overvalued describes a great many assets that are on the books as "rock-solid investments." Illiquidity...

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks – Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organizations, including the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and the American Public Health Association...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a session volume of 160.9 million compared to the average volume of 4.03 million as per data from Benzinga Pro.What HappenedZyVersa Therapeutics provided regulatory and product support for FDA-authorized Emergency Compassionate Use of Cholesterol Efflux Mediator VAR 200...

Wall Street Is On Fire—So Why Is This Wall Of Cash Moving Abroad? – iShares Core MSCI Emerging Markets ETF (ARCA:IEMG)

U.S. stocks may be breaking records, but a flood of investor cash is moving elsewhere—toward emerging markets, where valuations are cheaper, currencies are strengthening and years of underperformance may finally be reversing.The iShares Core MSCI Emerging Markets ETF IEMG has attracted $7.4 billion in inflows so far...

Why CARGO Therapeutics Stock Is Gaining Today – Cargo Therapeutics (NASDAQ:CRGX)

CARGO Therapeutics Inc. CRGX saw its stock climb on Tuesday after the biotech firm announced a merger agreement with Concentra Biosciences LLC.Under the terms of the agreement, Concentra will acquire CARGO for $4.379 in cash per share, along with a non-transferable contingent value right.The CVR entitles shareholders...

Gold Prices Slip Amid Trump’s Tariff Delay and Fed Rate Cut Speculations

Gold Pressured by Trade Tariffs On Monday, U.S. President Donald Trump posted letters on Truth Social addressed to the leaders of 14 countries. He threatened to impose tariffs ranging from 25% to 40% on imports unless countries address trade imbalances. The letters targeted China, Germany, Japan, Mexico, and...

Artelo Biosciences Analyst See It As An Emerging Biotech – Artelo Biosciences (NASDAQ:ARTL)

D. Boral Capital upgraded Artelo Biosciences, Inc. ARTL on Tuesday.The analyst upgraded from Hold to Buy and introduced a price forecast of $20.Analyst Jason Kolbert wrote, “We continue to view Artelo as an emerging biotechnology company focused on Cachexia and chemotherapy-induced peripheral neuropathy (CIN) with the lead...

Oil Prices Rebound Despite OPEC+ Output Hike as Markets Rethink Supply Risk

surged yesterday after gapping down over the weekend. The gap down came about as the + group, which includes OPEC and its allies, agreed to increase oil production by 548,000 barrels per day in August. This is a bigger rise compared to the 411,000 barrels per day...

Asian Stocks Climb as Trump Signals Openness to Trade Talks Before Tariff Deadline

Asian stock markets remained steady despite the latest update on US President Donald Trump’s tariff plans. On Tuesday, the stayed strong, and dropped. In the US, stock prices fell after Trump sent letters to 14 countries, including Japan and South Korea, announcing much higher tariffs on...

Why Is Cogent Biosciences Stock Soaring On Tuesday? – Cogent Biosciences (NASDAQ:COGT)

On Monday, Cogent Biosciences, Inc. COGT said bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis.The company said that its experimental drug reduced the symptoms of a chronic immune disorder called non-advanced systemic mastocytosis.The latest study demonstrated meaningful and highly statistically significant improvements across the...

Are Markets Underpricing the Next Tariff Shock?

Economic activity appears set to strengthen in the official Q2 , but the second half of the year looks relatively vulnerable. One factor is the possibility that the simmering trade war may heat up after President Trump on Monday announced new tariffs set to begin on August...

Does Higher Dose Of Wegovy Result In More Weight Loss – Novo Nordisk (NYSE:NVO)

Novo Nordisk A/S NVO on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy (subcutaneous semaglutide 7.2 mg).The submission is based on clinical data from the STEP UP and STEP...